The "Radiopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Thousand by the following Segments:

  • Diagnostic Radiopharmaceuticals
  • Therapeutic Radiopharmaceuticals

The report profiles 61 companies including many key and niche players such as:

  • Actinium Pharmaceuticals, Inc. (USA)
  • Alliance Medical (UK)
  • Alseres Pharmaceuticals, Inc. (USA)
  • Avid Radiopharmaceuticals (USA)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bracco Diagnostics, Inc. (USA)
  • Cardinal Health, Inc. (USA)
  • GE Healthcare (UK)
  • Ion Beam Applications S.A (Belgium)
  • Immunomedics, Inc. (USA)
  • Jubilant Pharma (India)
  • Lantheus Medical Imaging Inc. (USA)
  • Medi-Radiopharma Ltd (Hungary)
  • Nordion, Inc. (Canada)
  • Peregrine Pharmaceuticals, Inc. (USA)
  • PETNET Solutions Inc. (USA)
  • Positron Corporation (USA)
  • Triad Isotopes, Inc. (USA)

Key Topics Covered:

1. Industry Overview

2. Longstanding Growth Drivers

3. Product Overview

4. Product Innovations/Introductions

5. Recent Industry Activity

6. Focus On Select Players

7. Global Market Perspective

Total Companies Profiled: 61 (including Divisions

Subsidiaries 69)

  • The United States (27)
  • Canada (4)
  • Japan (1)
  • Europe (28)
    • France (4)
    • Germany (5)
    • The United Kingdom (4)
    • Italy (2)
    • Rest of Europe (13)
  • Asia-Pacific (Excluding Japan) (8)
  • Africa (1)

For more information about this report visit https://www.researchandmarkets.com/research/dv6kh6/global?w=4